Literature DB >> 24427652

Craniocaudal extension as an indication of surgical outcome in transsphenoidal surgery for pituitary adenomas.

Ossama Hamid1, Adel El Hakim2, Hossam El Husseiny3, Lobna El Fiky4, Sherif Kamel5.   

Abstract

Transsphenoidal approach is considered the treatment of choice for pituitary adenoma removal. Suprasellar extension is regarded a drawback for complete removal of these tumors through this approach. Evaluate the correlation between the preoperative radiologic craniocaudal extension on MRI of pituitary adenomas and the extent of tumor removal. A retrospective study. Tertiary care hospital. 560 patients underwent transsphenoidal removal of pituitary adenomas. The degree of removal of pituitary tumor in the follow-up imaging of the patients was correlated with the preoperative extension in mid-Coronal T1 W Gd. Tumors with suprasellar extension can be classified into: Type I tumors with extension confined to the sellar boundaries, resulted in complete removal in all cases (100%), type II tumors with suprasellar extension reaching the floor of the 3rd ventricle, resulted in complete removal in 70.2% of the cases, type III tumors with suprasellar extension above the 3rd ventricle, had only 13.5% of complete removal. Integration of radiologic findings into a scheme for the preoperative determination of possibility of total removal of the tumor through transsphenoidal approach, can give better correlation to the surgical outcome of pituitary tumors.

Entities:  

Keywords:  Pituitary adenomas; Radioanatomical classification; Surgical outcome; Transsphenoidal pituitary surgery

Year:  2011        PMID: 24427652      PMCID: PMC3738798          DOI: 10.1007/s12070-011-0350-3

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  22 in total

1.  Resection of suprasellar tumors by using a modified transsphenoidal approach. Report of four cases.

Authors:  J G Kouri; M Y Chen; J C Watson; E H Oldfield
Journal:  J Neurosurg       Date:  2000-06       Impact factor: 5.115

2.  Variations on the standard transsphenoidal approach to the sellar region, with emphasis on the extended approaches and parasellar approaches: surgical experience in 105 cases.

Authors:  William T Couldwell; Martin H Weiss; Craig Rabb; James K Liu; Ronald I Apfelbaum; Takanori Fukushima
Journal:  Neurosurgery       Date:  2004-09       Impact factor: 4.654

Review 3.  The transsphenoidal approach. A historical perspective.

Authors:  Adam S Kanter; Aaron S Dumont; Ashok R Asthagiri; Rod J Oskouian; John A Jane; Edward R Laws
Journal:  Neurosurg Focus       Date:  2005-04-15       Impact factor: 4.047

4.  A simplified direct endonasal approach for transsphenoidal surgery.

Authors:  M Nejadkazem; A Samii; R Fahlbusch; S Bidadi
Journal:  Minim Invasive Neurosurg       Date:  2008-10-14

Review 5.  The cytogenesis and pathogenesis of pituitary adenomas.

Authors:  S L Asa; S Ezzat
Journal:  Endocr Rev       Date:  1998-12       Impact factor: 19.871

Review 6.  Transcranial surgery for pituitary adenomas.

Authors:  A Samy Youssef; Siviero Agazzi; Harry R van Loveren
Journal:  Neurosurgery       Date:  2005-07       Impact factor: 4.654

Review 7.  Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry.

Authors:  Wolfgang Saeger; Dieter K Lüdecke; Michael Buchfelder; Rudolf Fahlbusch; Hans-Jürgen Quabbe; Stephan Petersenn
Journal:  Eur J Endocrinol       Date:  2007-02       Impact factor: 6.664

8.  Endonasal transsphenoidal pituitary surgery: is tumor volume a key factor in determining outcome?

Authors:  Amit Kumar Jain; Ashok Kumar Gupta; Ashis Pathak; Anil Bhansali; J Rajiv Bapuraj
Journal:  Am J Otolaryngol       Date:  2008 Jan-Feb       Impact factor: 1.808

Review 9.  Transsphenoidal surgery.

Authors:  Shabin Man Joshi; Simon Cudlip
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

10.  Technical considerations of transsphenoidal removal of fibrous pituitary adenomas and evaluation of collagen content and subtype in the adenomas.

Authors:  Hirofumi Naganuma; Eiji Satoh; Hideaki Nukui
Journal:  Neurol Med Chir (Tokyo)       Date:  2002-05       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.